The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...

Mylan’s long-awaited rival for Teva’s blockbuster multiple sclerosis drug Copaxone has been approved in the US, putting a large chunk of the Israeli firm’s revenues at risk. The timing could not have ...

Confined to the house with chronic illness, Louise Kenward discovered a community of artists continuing to connect with the natural worlds from their beds and homes. Here, she explores the rich and ...